Nutrigenomics in the whole-genome scanning era: Crohn's disease as example

Cellular and Molecular Life Sciences

Volumn 64, Issue 23, 2007, Pages 3105-3118

  Ferguson, L R ^a,b   Philpott, M ^a,b   Dryland, P ^a,b  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b Nutrigenomics New Zealand   (New Zealand)

Author keywords

Crohn's disease; Genome wide association study; Nutrigenomics; Single nucleotide polymorphism

Indexed keywords

AUTOPHAGY RELATED 16 LIKE 1 PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CORTICOSTEROID; INTERLEUKIN 23; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PATTERN RECOGNITION RECEPTOR; PROBIOTIC AGENT; PROTEIN DERIVATIVE; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

AUTOPHAGY; CELIAC DISEASE; CROHN DISEASE; DIET; FOOD; GENE IDENTIFICATION; GENOME; GENOMICS; HEALTH; HLA SYSTEM; HUMAN; LINKAGE ANALYSIS; NONHUMAN; NUTRIGENOMICS; PROTEIN INDUCTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 38549103697     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-7303-8     Document Type: Review

References (115)

1. Afman, L. and Muller, M. (2006) Nutrigenomics: from molecular nutrition to prevention of disease. J. Am. Diet. Assoc. 106, 569-576.
2. Kim, O. J., Hong, S. P., Ahn, J. Y., Hong, S. H., Hwang, T. S., Kim, S. O., Yoo, W., Oh, D. and Kim, N. K. (2007) Influence of combined methionine synthase (MTR 2756A > G) and methylenetetrahydrofolate reductase (MTHFR 677C > T) polymorphisms to plasma homocysteine levels in Korean patients with ischemic stroke. Yonsei Med. J. 48, 201-209.
3. Low, Y. L. and Tai, E. S. (2007) Understanding diet-gene interactions: lessons from studying nutrigenomics and cardiovascular disease. Mutat. Res. 622, 7-13.
4. Ordovas, J. M. (2006) Genetic interactions with diet influence the risk of cardiovascular disease. Am. J. Clin. Nutr. 83, 443S-446S.
5. Gorman, C. (2006) Does my diet fit my genes? The new science of nutrigenomics has some answers. It explains why fat and caffeine are worse for some than others. Time 167, 69-70.
6. Subbiah, M. T. R. (2007) Nutrigenetics and nutraceuticals: the next wave riding on personalized medicine. Transl. Res. 149, 55-61.
7. Rioux, J. D., Xavier, R. J., Taylor, K. D., Silverberg, M. S., Goyette, P., Huett, A., Green, T., Kuballa, P., Barmada, M. M., Datta, L. W., Shugart, Y. Y., Griffiths, A. M. et al. (2007) Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39, 596-604.
8. Wellcome Trust Case Control Consortium. (2007) Genomewide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678.
9. Brant, S. R. and Shugart, Y. Y. (2004) Inflammatory bowel disease gene hunting by linkage analysis: rationale, methodology, and present status of the field. Inflamm. Bowel Dis. 10, 300-311.
10. Pena, A. S. (1998) Genetics of inflammatory bowel disease. The candidate gene approach: susceptibility versus disease heterogeneity. Dig. Dis. 16, 356-363.
11. Online Mendelian Inheritance in Man. (2007) http://www.ncbi.nlm.nih.gov/ entrez/dispomim.cgi?id=266600.
12. Hugot, J. P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J. P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., Binder, V., Finkel, Y. et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603.
13. Hugot, J. P., Laurent-Puig, P., Gower-Rousseau, C., Olson, J. M., Lee, J. C., Beaugerie, L., Naom, I., Dupas, J. L., Van Gossum, A., Orholm, M., Bonaiti-Pellie, C., Weissenbach, J. et al. (1996) Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379, 821-823
14. Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., Achkar, J. P., Brant, S. R. et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606.
15. Browning, B. L., Huebner, C., Petermann, I., Gearry, R. B., Barclay, M. L., Shelling, A. N. and Ferguson, L. R. (in press) Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am. J. Gastroenterol. (in press).
16. Ferguson, L. R., Shelling, A. N., Browning, B. L., Huebner, C. and Petermann, I. (2007) Genes, diet and inflammatory bowel disease. Mutat. Res. 622, 70-83.
17. Klein, W., Tromm, A., Folwaczny, C., Hagedorn, M., Duerig, N., Epplen, J., Schmiegel, W. and Griga, T. (2005) The G2964A polymorphism of the STAT6 gene in inflammatory bowel disease. Dig. Liver Dis. 37, 159-161.
18. van Heel, D. A. , Fisher, S. A., Kirby, A., Daly, M. J. , Rioux, J. D. and Lewis, C. M. (2004) Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum. Mol. Genet. 13, 763-770.
19. Duerr, R. H., Barmada, M. M., Zhang, L., Pfutzer, R. and Weeks, D. E. (2000) High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. Am. J. Hum. Genet. 66, 1857-1862.
20. Ma, Y., Ohmen, J. D., Li, Z., Bentley, L. G., McElree, C., Pressman, S., Targan, S. R., Fischel-Ghodsian, N., Rotter, J. I. and Yang, H. (1999) A genome-wide search identifies potential new susceptibility loci for Crohn's disease. Inflamm. Bowel Dis. 5, 271-278.
21. Pierik, M., Yang, H., Barmada, M. M., Cavanaugh, J. A., Annese, V., Brant, S. R., Cho, J. H., Duerr, R. H., Hugot, J. P., McGovern, D. P., Paavola-Sakki, P., Radford-Smith, G. L. et al. (2005) The IBD international genetics consortium provides further evidence for linkage to IBD4 and shows gene-environment interaction. Inflamm. Bowel Dis. 11, 1-7.
22. Silverberg, M. S., Duerr, R. H., Brant, S. R., Bromfield, G., Datta, L. W., Jani, N., Kane, S. V., Rotter, J. I., Philip Schumm, L., Hillary Steinhart, A., Taylor, K. D., Yang, H. et al. (2007) Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease. Eur. J. Hum. Genet. 15, 328-335.
23. Silverberg, M.-S. (2006) OCTNs: will the real IBD5 gene please stand up? World J. Gastroenterol. 12, 3678-3681.
24. Tello-Ruiz, M. K., Curley, C., DelMonte, T., Giallourakis, C., Kirby, A., Miller, K., Wild, G., Cohen, A., Langelier, D., Latiano, A., Wedemeyer, N., Lander, E. et al. (2006) Haplotype-based association analysis of 56 functional candidate genes in the IBD6 locus on chromosome 19. Eur. J. Hum. Genet. 14, 780-790.
25. Cho, J. (2000) Update on inflammatory bowel disease genetics. Curr. Gastroenterol. Rep. 2, 434-439.
26. Cho, J. H., Nicolae, D. L., Gold, L. H., Fields, C. T., LaBuda, M. C., Rohal, P. M., Pickles, M. R., Qin, L., Fu, Y., Mann, J. S., Kirschner, B. S., Jabs, E. W. et al. (1998) Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc. Natl. Acad. Sci. USA 95, 7502-7507.
27. Rosenberg, I. M., Goke, M., Kanai, M., Reinecker, H. C. and Podolsky, D. K. (1997) Epithelial cell kinase-B61: an autocrine loop modulating intestinal epithelial migration and barrier function. Am. J. Physiol. 273, G824-G832.
28. Hampe, J., Frenzel, H., Mirza, M. M., Croucher, P. J., Cuthbert, A., Mascheretti, S., Huse, K., Platzer, M., Bridger, S., Meyer, B., Nurnberg, P., Stokkers, P. et al. (2002) Evidence for a NOD2-independent susceptibility locus for inflammatory bowel disease on chromosome 16p. Proc. Natl. Acad. Sci. USA 99, 321-326.
29. Duerr, R. H., Barmada, M. M., Zhang, L., Achkar, J. P., Cho, J. H., Hanauer, S. B., Brant, S. R., Bayless, T. M., Baldassano, R. N. and Weeks, D. E. (2002) Evidence for an inflammatory bowel disease locus on chromosome 3p26: linkage, transmission/ disequilibrium and partitioning of linkage. Hum. Mol. Genet. 11, 2599-2606.
30. Hampe, J., Lynch, N. J., Daniels, S., Bridger, S., Macpherson, A. J., Stokkers, P., Forbes, A., Lennard-Jones, J. E., Mathew, C. G., Curran, M. E. and Schreiber, S. (2001) Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease. Gut 48, 191-197.
31. Satsangi, J., Parkes, M., Louis, E., Hashimoto, L., Kato, N., Welsh, K., Terwilliger, J. D., Lathrop, G. M., Bell, J. I. and Jewell, D. P. (1996) Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat. Genet. 14, 199-202.
32. Daly, M. J. and Rioux, J. D. (2004) New approaches to gene hunting in IBD. Inflamm. Bowel Dis. 10, 312-317.
33. Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., Dassopoulos, T., Bitton, A. et al. (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463.
34. Libioulle, C., Louis, E., Hansoul, S., Sandor, C., Farnir, F., Franchimont, D., Vermeire, S., Dewit, O., de Vos, M., Dixon, A., Demarche, B., Gut, I. et al. (2007) Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 3, e58.
35. Hampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., De La Vega, F. M., Briggs, J., Gunther, S., Prescott, N. J. et al. (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39, 207-211.
36. Clark, A. G. and Li, J. (2007) Conjuring SNPs to detect associations Nat. Genet. 39, 815-816.
37. Singh, S. B., Davis, A. S., Taylor, G. A. and Deretic, V. (2006) Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313, 1438-1441.
38. Jimenez-Sanchez, G., Childs, B. and Valle, D. (2001) Human disease genes. Nature 409, 853-855.
39. Altmuller, J., Palmer, L. J., Fischer, G., Scherb, H. and Wjst, M. (2001) Genomewide scans of complex human diseases: true linkage is hard to find. Am. J. Hum. Genet. 69, 936-950.
40. Risch, N. and Merikangas, K. (1996) The future of genetic studies of complex human diseases. Science 273, 1516-1517.
41. Wang, W. Y. S., Barratt, B. J., Clayton, D. G. and Todd, J. A. (2005) Genome-wide association studies: theoretical and practical concerns. Nat. Rev. Genet. 6, 109-118.
42. Girardin, S. E., Boneca, I. G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D. J. and Sansonetti, P. J. (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869-8872.
43. Hampe, J., Cuthbert, A., Croucher, P. J., Mirza, M. M., Mascheretti, S., Fisher, S., Frenzel, H., King, K., Hasselmeyer, A., MacPherson, A. J., Bridger, S., van Deventer, S. et al. (2001) Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357, 1925-1928.
44. Bonen, D. K., Ogura, Y., Nicolae, D. L., Inohara, N., Saab, L., Tanabe, T., Chen, F. F., Foster, S. J., Duerr, R. H., Brant, S. R., Cho, J. H. and Nunez, G. (2003) Crohn's disease associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 124, 140-146.
45. Watanabe, T., Kitani, A., Murray, P. J., Wakatsuki, Y., Fuss, I. J. and Strober, W. (2006) Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity 25, 473-485.
46. Strober, W., Murray, P. J., Kitani, A. and Watanabe, T. (2006) Signalling pathways and molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol. 6, 9-20.
47. Hugot, J.-P. (2006) CARD15/NOD2 mutations in Crohn's disease. Ann. NY Acad. Sci. 1072, 9-18.
48. Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., McKenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., Murphy, E., Sathe, M. et al. (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116, 1310-1316.
49. Fuss, I. J., Becker, C., Yang, Z., Groden, C., Hornung, R. L., Heller, F., Neurath, M. F., Strober, W. and Mannon, P. J. (2006) Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody. Inflamm. Bowel Dis. 12, 9-15.
50. Mannon, P. J., Fuss, I. J., Mayer, L., Elson, C. O., Sandborn, W. J., Present, D., Dolin, B., Goodman, N., Groden, C., Hornung, R. L., Quezado, M., Yang, Z. et al. (2004) Anti-interleukin-12 antibody for active Crohn's disease. N. Engl. J. Med. 351, 2069-2079.
51. Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., Ichikawa, A. and Narumiya, S. (2002) The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J. Clin. Invest. 109, 883-893.
52. Muller, A. J. and Scherle, P. A. (2006) Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors. Nat. Rev. Cancer 6, 613-625.
53. Baratelli, F., Lin, Y., Zhu, L., Yang, S.-C., Heuze-Vourc'h, N., Zeng, G., Reckamp, K., Dohadwala, M., Sharma, S. and Dubinett, S. M. (2005) Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J. Immunol. 175, 1483-1490.
54. Sharma, S., Yang, S.-C., Zhu, L., Reckamp, K., Gardner, B., Baratelli, F., Huang, M., Batra, R. K. and Dubinett, S. M. (2005) Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer. Cancer Res. 65, 5211-5220.
55. Matsushita, M., Suzuki, N. N., Obara, K., Fujioka, Y., Ohsumi, Y. and Inagaki, F. (2007) Structure of Atg5.Atg16, a complex essential for autophagy. J. Biol. Chem. 282, 6763-6772.
56. Mizushima, N., Kuma, A., Kobayashi, Y., Yamamoto, A., Matsubae, M., Takao, T., Natsume, T., Ohsumi, Y. and Yoshimori, T. (2003) Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate. J. Cell. Sci. 116, 1679-1688.
57. Mizushima, N. (2005) The pleiotropic role of autophagy: from protein metabolism to bactericide. Cell Death Differ. 12 (suppl. 2), 1535-1541.
58. Amano, A., Nakagawa, I. and Yoshimori, T. (2006) Autophagy in innate immunity against intracellular bacteria. J. Biochem. 140, 161-166.
59. Lutz, M. A. and Correll, P. H. (2003) Activation of CR3-mediated phagocytosis by MSP requires the RON receptor, tyrosine kinase activity, phosphatidylinositol 3-kinase, and protein kinase C zeta. J. Leukoc. Biol. 73, 802-814.
60. Hirano, S., Anuradha, C. D. and Kanno, S. (2000) Transcription of krox-20/egr-2 is upregulated after exposure to fibrous particles and adhesion in rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 23, 313-319.
61. Reis e Sousa, C. (2007) Immunology: eating in to avoid infection. Science 315, 1376-1377.
62. Lee, H. K., Lund, J. M., Ramanathan, B., Mizushima, N. and Iwasaki, A. (2007)Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315, 1398-1401.
63. Husebye, H., Halaas, O., Stenmark, H., Tunheim, G., Sandanger, O., Bogen, B., Brech, A., Latz, E. and Espevik, T. (2006) Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBOJ. 25, 683-692.
64. Wang, S., Raven, J. F., Baltzis, D., Kazemi, S., Brunet, D. V., Hatzoglou, M., Tremblay, M. L. and Koromilas, A. E. (2006) The catalytic activity of the eukaryotic initiation factor-2alpha kinase PKR is required to negatively regulate Stat1 and Stat3 via activation of the T-cell protein-tyrosine phosphatase. J. Biol. Chem. 281, 9439-9449.
65. Lu, X., Chen, J., Sasmono, R. T., Hsi, E. D., Sarosiek, K. A., Tiganis, T. and Lossos, I. S. (2007) T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6. Mol. Cell. Biol. 27, 2166-2179.
66. Lu, X., Nechushtan, H., Ding, F., Rosado, M. F., Singal, R., Alizadeh, A. A. and Lossos, I. S. (2005) Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas. Blood 105, 2924-2932.
67. Schmid, D., Dengjel, J., Schoor, O., Stevanovic, S. and Munz, C. (2006) Autophagy in innate and adaptive immunity against intracellular pathogens. J. Mol. Med. 84, 194-202.
68. Kim, W.-J., Bae, E.-M., Kang, Y.-J., Bae, H.-U., Hong, S. H., Lee, J. Y., Park, J.-E., Kwon, B. S., Suk, K. and Lee, W.-H. (2006) Glucocorticoid-induced tumour necrosis factor receptor family related protein (GITR) mediates inflammatory activation of macrophages that can destabilize atherosclerotic plaques. Immunology 119, 421-429.
69. Migone, T. S., Zhang, J., Luo, X., Zhuang, L., Chen, C., Hu, B., Hong, J. S., Perry, J. W., Chen, S. F., Zhou, J. X. H., Cho, Y. H., Ullrich, S. et al. (2002) TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16, 479-492.
70. Beyaert, R., Heyninck, K. and Van Huffel, S. (2000) A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. Biochem. Pharmacol. 60, 1143-1151.
71. Esparza, E. M. and Arch, R. H. (2005) Glucocorticoid-induced TNF receptor, a costimulatory receptor on naive and activated T cells, uses TNF receptor-associated factor 2 in a novel fashion as an inhibitor of NF-kappa B activation. J. Immunol. 174, 7875-7882.
72. O'Grady, E., Mulcahy, H., Adams, C., Morrissey, J. P. and O'Gara, F. (2007) Manipulation of host Kruppel-like factor (KLF) function by exotoxins from diverse bacterial pathogens. Nat. Rev. Microbiol. 5, 337-341.
73. Woolner, J. T., Parker, T. J., Kirby, G. A. and Hunter, J. O. (1998) The development and evaluation of a diet for maintaining remission in Crohn's disease. J. Hum. Nutr. Diet. 11, 1-11.
74. Jones, J. L. and Foxx-Orenstein, A. E. (2007) The role of probiotics in inflammatory bowel disease. Dig. Dis. Sci. 52, 607-611.
75. Cukovic-Cavka, S., Likic, R., Francetic, I., Rustemovic, N., Opacic, M. and Vucelic, B. (2006) Lactobacillus acidophilus as a cause of liver abscess in a NOD2/CARD15-positive patient with Crohn's disease. Digestion 73, 107-110.
76. Lim, C. C., Ferguson, L. R. and Tannock, G. W. (2005) Dietary fibres as 'prebiotics': implications for colorectal cancer. Mol. Nutr. Food Res. 49, 609-619.
77. Lionetti, P., Callegari, M. L., Ferrari, S., Cavicchi, M. C., Pozzi, E., de Martino, M. and Morelli, L. (2005) Enteral nutrition and microflora in pediatric Crohn's disease. J. Parenter. Enter. Nutr. 29, S173-S175; discussion S175-S178.
78. Philpott, M., Mackay, L., Ferguson, L. R., Forbes, D. and Skinner, M. (2007) Cell culture models in developing nutrigenomics foods for inflammatory bowel disease. Mutat. Res. 622, 94-102.
79. Borthakur, A., Bhattacharyya, S., Dudeja, P. K. and Tobacman, J. K. (2007) Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G829-G838.
80. Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L. and Schwartz, D. A. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25, 187-191.
81. Lee, J. Y., Ye, J., Gao, Z., Youn, H. S., Lee, W. H., Zhao, L., Sizemore, N. and Hwang, D. H. (2003) Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J. Biol. Chem. 278, 37041-37051.
82. Sadeghi, K., Wessner, B., Laggner, U., Ploder, M., Tamandl, D., Friedl, J., Zugel, U., Steinmeyer, A., Pollak, A., Roth, E., Boltz-Nitulescu, G. and Spittler, A. (2006) Vitamin D3 downregulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur. J. Immunol. 36, 361-370.
83. Gremy, O., Benderitter, M. and Linard, C. (2006) Caffeic acid phenethyl ester modifies the Th1/Th2 balance in ileal mucosa after gamma-irradiation in the rat by modulating the cytokine pattern. World J. Gastroenterol. 12, 4996-5004.
84. Roy, N., Barnett, M., Knoch, B., Dommels, Y. and McNabb, W. (2007) Nutrigenomics applied to an animal model of inflammatory bowel diseases: transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets. Mutat. Res. 622, 103-116.
85. Kelekar, A. (2005)Autophagy. Ann. NY Acad. Sci. 1066, 259-271.
86. Kadowaki, M., Karim, M. R., Carpi, A. and Miotto, G. (2006) Nutrient control of macroautophagy in mammalian cells. Mol. Aspects Med. 27, 426-443.
87. Scherz-Shouval, R., Shvets, E., Fass, E., Shorer, H., Gil, L. and Elazar, Z. (2007) Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 26, 1749-1760.
88. Hazan, R., Levine, A. and Abeliovich, H. (2004) Benzoic acid, a weak organic acid food preservative, exerts specific effects on intracellular membrane trafficking pathways in Saccharomyces cerevisiae. Appl. Environ. Microbiol. 70, 4449-4457.
89. Lavieu, G., Scarlatti, F., Sala, G., Carpentier, S., Levade, T., Ghidoni, R., Botti, J. and Codogno, P. (2006) Regulation of autophagy by sphingosine kinase 1 and its role in cell survival during nutrient starvation. J. Biol. Chem. 281, 8518-8527.
90. Gossner, G., Choi, M., Tan, L., Fogoros, S., Griffith, K. A., Kuenker, M. and Liu, J. R. (2007) Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecol. Oncol. 105, 23-30.
91. Onodera, J. and Ohsumi, Y. (2005) Autophagy is required for maintenance of amino acid levels and protein synthesis under nitrogen starvation. J. Biol. Chem. 280, 31582-31586.
92. Koning, F., Schuppan, D., Cerf-Bensussan, N. and Sollid, L. (2005) Pathomechanisms in celiac disease. Best Pract. Res. Clin. Gastroenterol. 19, 373-387.
93. Karinen, H., Kärkkäinen, P., Pihlajamäki, J., Janatuinen, E., Heikkinen, M., Julkunen, R., Kosma, V.-M., Naukkarinen, A. and Laakso, M. (2006) Gene dose effect of the DQB1*0201 allele contributes to severity of coeliac disease. Scand. J. Gastroenterol. 41, 191-199.
94. Alp, M. H. and Wright, R. (1971) Autoantibodies to reticulin in patients with idiopathic steatorrhoea, coeliac disease, and Crohn's disease and their relation to immunoglobulins and dietary antibodies. Lancet 298, 682-685.
95. Doe, W. F. and Brown, D. (1973) Evidence for circulating immune complexes in inflammatory bowel disease and adult coeliac disease. Gut 14, 429.
96. Schedel, J., Rockmann, F., Bongartz, T., Woenckhaus, M., Schölmerich, J. and Kullmann, F. (2005) Association of Crohn's disease and latent celiac disease: a case report and review of the literature. Int. J. Colorectal Dis. 20, 376-380.
97. Stepniak, D. and Koning, F. (2006) Enzymatic gluten detoxification: the proof of the pudding is in the eating! Trends Biotechnol. 24, 433-434.
98. Stepniak, D. and Koning, F. (2006) Celiac disease - sandwiched between innate and adaptive immunity. Hum. Immunol. 67, 460-468.
99. Tursi, A., Giorgetti, G. M., Brandimarte, G. and Elisei, W. (2005) High prevalence of celiac disease among patients affected by Crohn's disease. Inflamm. Bowel Dis. 11, 662-666.
100. James, A. H. (1977) Breakfast and Crohn's disease. BMJ i, 943-945.
101. Brandtzaeg, P. (2006) The changing immunological paradigm in coeliac disease. Immunol. Lett. 105, 127-139.
102. van Herpen, T., Goryunova, S., van der Schoot, J., Mitreva, M., Salentijn, E., Vorst, O., Schenk, M., van Veelen, P., Koning, F., van Soest, L., Vosman, B., Bosch, D. et al. (2006) Alpha-gliadin genes from the A, B, and D genomes of wheat contain different sets of celiac disease epitopes. BMC Genom. 7, 1.
103. Spaenij-Dekking, L., Kooy-Winkelaar, Y., van Veelen, P., Drijfhout, J., Jonker, H., van Soest, L., Smulders, M., Bosch, D., Gilissen, L. and Koning, F. (2005) Natural variation in toxicity of wheat: potential for selection of nontoxic varieties for celiac disease patients. Gastroenterology 129, 797-806.
104. Stepniak, D., Vader, L., Kooy, Y., van Veelen, P., Moustakas, A., Papandreou, N., Eliopoulos, E., Drijfhout, J., Papadopoulos, G. and Koning, F. (2005) T-cell recognition of HLADQ2-bound gluten peptides can be influenced by an N-terminal proline at p-1. Immunogenetics 57, 8-15.
105. Vader, L., Stepniak, D., Bunnik, E., Kooy, Y., de Haan, W., Drijfhout, J., Van Veelen, P. and Koning, F. (2003) Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology 125, 1105-1113.
106. Pizzuti, D., Buda, A., D'Odorico, A., D'Inca, R., Chiarelli, S., Curioni, A. and Martines, D. (2006) Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients Scand. J. Gastroenterol. 41, 1305-1311.
107. Senger, S., Maurano, F., Mazzeo, M., Gaita, M., Fierro, O., David, C., Troncone, R., Auricchio, S., Siciliano, R. and Rossi, M. (2005) Identification of immunodominant epitopes of alpha-gliadin in HLA-DQ8 transgenic mice following oral immunization. J. Immunol. 175, 8087-8095.
108. Kemppainen, T., Janatuinen, E., Holm, K., Kosma, V., Heikkinen, M., Maki, M., Laurila, K., Uusitupa, M. and Julkunen, R. (2007) No observed local immunological response at cell level after five years of oats in adult coeliac disease. Scand. J. Gastroenterol. 42, 54-59.
109. Ludvigsson, J., Eylert, M., Ilonen, J., Ludvigson, J. and Vaarala, O. (2006) Effect of HLA DQ2, dietary exposure and coeliac disease on the development of antibody response to gliadin in children. Scand. J. Gastroenterol. 41, 919-928.
110. The ENCODE Project Consortium. (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799-816.
111. Kapranov, P., Willingham, A. T. and Gingeras, T. R. (2007) Genome-wide transcription and the implications for genomic organization. Nat. Rev. Genet. 8, 413-423.
112. Henikoff, S. (2007) ENCODE and our very busy genome. Nat. Genet. 39 817-818.
113. Foster, S. L., Hargreaves, D. C. and Medzhitov, R. (2007) Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447, 972-978.
114. Shelling, A. N. and Ferguson, L. R. (2007) Genetic variation in human disease and a new role for copy number variants. Mutat. Res. 622, 33-41.
115. Fellermann, K., Stange, D. E., Schaeffeler, E., Schmalzl, H., Wehkamp, J., Bevins, C. L., Reinisch, W., Teml, A., Schwab, M., Lichter, P., Radlwimmer, B. and Stange, E. F. (2006) A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am. J. Hum. Genet. 79, 439-448.